Treanda (bendamustine hydrochloride)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Treanda (bendamustine hydrochloride), covering 2018-06-07 to 2018-07-02. Get the full timeline:
Most recent: Clinical Trial Update: CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma [Phase 1]